Randomised controlled trials in severe asthma: selection by phenotype or stereotype Source: Eur Respir J, 53 (2) 1802187; 10.1183/13993003.02187-2018 Year: 2019
Randomised controlled trials in severe asthma: selection by phenotype or stereotype Source: Eur Respir J, 52 (6) 1801444; 10.1183/13993003.01444-2018 Year: 2018
Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial Source: ERJ Open Res, 7 (3) 00738-2020; 10.1183/23120541.00738-2020 Year: 2021
Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019
Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020 Year: 2020
Lower incidence of asthma exacerbations with FE NO-guided anti-inflammatory treatment: A randomised controlled trial Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012
Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
Methotrexate in treatment of severe difficult-to-treat asthma: randomized, double-blind, placebo-controlled study Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020
Enhancing self-regulation skills in teenagers with severe asthma: A controlled randomised trial Source: Eur Respir J 2003; 22: Suppl. 45, 366s Year: 2003
Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018
Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement Year: 2018
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Effects of Roflumilast on subclinical atherosclerosis in COPD - a randomized controlled trial Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017